Research ArticlePart A
Evaluation of 19-Nor-2α-(3-hydroxypropyl)-1α,25-dihydroxyvitamin D3 as a Therapeutic Agent for Androgen-dependent Prostate Cancer
JOHN N. FLANAGAN, SHASHA ZHENG, KUN-CHUN CHIANG, ATSUSHI KITTAKA, TOSHIYUKI SAKAKI, SACHIE NAKABAYASHI, XIANSI ZHAO, REMCO A. SPANJAARD, KELLY S. PERSONS, JEFFREY S. MATHIEU, MICHAEL F. HOLICK and TAI C. CHEN
Anticancer Research September 2009, 29 (9) 3547-3553;